ETON PHARMACEUTICALS

Serial Number 87443234
602

Registration Progress

Application Filed
May 9, 2017
Under Examination
Dec 12, 2017
Approved for Publication
Oct 17, 2017
Published for Opposition
Oct 17, 2017
Registered

Trademark Image

ETON PHARMACEUTICALS

Basic Information

Serial Number
87443234
Filing Date
May 9, 2017
Published for Opposition
October 17, 2017
Abandonment Date
July 9, 2020
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Jul 21, 2020
Classes
005

Rights Holder

ETON PHARMACEUTICALS, INC.

03
Address
21925 FIELD PARKWAY, SUITE 235
DEER PARK, IL 60010

Ownership History

IMPRIMIS PHARMACEUTICALS, INC.

Original Applicant
03
San Diego, CA

ETON PHARMACEUTICALS, INC.

New Owner Before Publication #1
03
DEER PARK, IL

ETON PHARMACEUTICALS, INC.

Owner at Publication
03
DEER PARK, IL

Legal Representation

Attorney
Antony M. Novom

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

37 events
Date Code Type Description Documents
Jul 21, 2020 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Jul 21, 2020 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Jan 8, 2020 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Jan 8, 2020 GNRT O NON-FINAL ACTION E-MAILED Loading...
Jan 8, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 16, 2019 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Dec 14, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 10, 2019 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Dec 10, 2019 IUAF S USE AMENDMENT FILED Loading...
Jun 14, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 12, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 12, 2019 EXT3 S SOU EXTENSION 3 FILED Loading...
Jun 12, 2019 EX3G S SOU EXTENSION 3 GRANTED Loading...
Dec 12, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 10, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 10, 2018 EXT2 S SOU EXTENSION 2 FILED Loading...
Dec 10, 2018 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jun 8, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 6, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 6, 2018 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 6, 2018 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 12, 2017 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 17, 2017 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 17, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 27, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 8, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 2, 2017 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 1, 2017 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 1, 2017 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 8, 2017 CPEA R EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED Loading...
Aug 8, 2017 EPEN O COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY Loading...
Aug 8, 2017 GEAP F EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Loading...
Aug 8, 2017 GEAN O NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Loading...
Aug 6, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 2, 2017 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
May 13, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 12, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical compositions for the treatment of fibrotic and autoimmune diseases, disorders and pathologies
First Use Anywhere: Jan 25, 2019
First Use in Commerce: Nov 13, 2019

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMACEUTICALS"